Expand the following panels for additional search options.

Tales From the Trenches: How to Successfully Use Statistics—Without Being a Data Guru

Mark Twain said there are “lies, damned lies and statistics.” Some valuation experts may be uncomfortable using statistics in an engagement. But you don’t have to be a statistics guru to successfully use them when the engagement calls for it. For instance, many damages litigations include the use of regression analyses and/or statistical sampling. Both are statistical methods of determining the amount of damages in a dispute.

New DealStats Hall of Fame members

DealStats now lists over 30,000 private-company and 4,000 public-company M&A transactions, thanks to business brokers and other intermediaries who contribute the data.

UK buyers deepen ‘local’ footprint with UK target companies

BVWire—UK had the pleasure of catching up with well-known experts Konstantine Mossios and Sandra Mossios of Business Valuation Benchmarks (BVB) at the ICAEW conference in London on 23 October.

DealStats adds 35 new fields of data, other enhancements

As of October 16, DealStats, the leading database of transactions in the private and public sectors, will have 35 new fields of data.

A Script for Pharmacy Valuation

The U.S. healthcare industry is very large, complex, and changing rapidly. This highly regulated industry is also a significant user of valuation services, primarily to support transactions, contracting, and internal strategic planning purposes. The importance of consummating transactions within fair market value cannot be overstated, as the alternative can result in substantial financial consequences to the parties involved. As such, advisors need to know the operational and valuation issues associated with healthcare entities so they ...

Global BVU News and Trends August 2019

Business valuation news from a global perspective.

EBITDA multiples by industry: 2Q 2019 analysis on private-company selling prices

Business Valuation Resources recently published EBITDA multiples by industry in our DealStats Value Index (DVI). DVI presents an aggregated summary of valuation multiples and profit margins for over 30,000 sold private companies listed in our DealStats database. This post includes some of the highlights from the report.

Meanwhile, the global value of control trends down slightly during Q1 2019

BVR has completed its latest quarterly update to the FactSet Mergerstat/BVR Control Premium Study (CPS), which includes an added 141 controlling acquisitions worldwide.

Industry Snapshot: Automobile Dealers

An at-a-glance overview and update on current trends, value drivers, and valuation approaches in the complex world of automobile dealerships.

BVU News and Trends May 2019

A monthly roundup of key developments of interest to business valuation experts.

What is acquiring control worth in the UK?

Quite a bit, it turns out—30%. Current data (including Q1 2019 updates) from the FactSet Mergerstat/BVR Control Premium Study (CPS), show that UK buyers value the future benefits of controlling interests higher than nearly anywhere else in the world.

Private-company selling price/EBITDA median is 4.4x, per DealStats

The median selling price/EBITDA multiple across all industry sectors is 4.4x, according to the 2Q 2019 DealStats Value Index (DVI).

Pratt’s Stats/Deal Stats analysis holds up in divorce litigation

A Maryland divorce case illustrates the difficulties an appraiser charged with valuing a small company in the divorce context may face and how he or she may prevail in court.

Valuations steady for A/E firms, per new study

Valuations of minority interests in privately held architecture, engineering, and environmental consulting firms (A/E firms) held steady from 2017 to 2018, according to a new study.

BVU News and Trends March 2019

A monthly roundup of key developments of interest to business valuation experts.

Private-company EBITDA multiples rise in the second half of 2018

After being down sharply in 2Q18, EBITDA multiples (median selling price/EBITDA) across all industries increased to 4.5x and 4.2x in the third and fourth quarters of 2018, respectively, according to the BVR’s DealStats Value Index (DVI).

BVU News and Trends February 2019

A monthly roundup of key developments of interest to business valuation experts.

Infographic reveals value predictor via DealStats analysis

BVR’s “What’s Your Company Worth?” infographic is as visually captivating as it is informative, concisely summarizing the most statistically significant predictor of value for each major NAICS industry.

EBITDA multiples by industry: New statistics on private-company selling prices

Highlights from an analysis of over 30,000 private-company acquisitions, including EBITDA multiples by industry and other statistics on selling prices and earning measures.

BVU News and Trends January 2019

A monthly roundup of key developments of interest to business valuation experts.

Surprising statistic on private firm multiples

A white paper, the “Private Business Valuation Market Update,” examines the median price-to-revenue metric private firm buyers paid for all private firms from 2003 to 2017.

BVU News and Trends November 2018

A monthly roundup of key developments of interest to business valuation experts.

Private-company EBITDA multiples down sharply in 2Q18

In the second quarter of 2018, EBITDA multiples (median selling price/EBITDA) for private companies plummeted to 2.8x, the largest decline reported in recent years, according to BVR’s DealStats Value Index (DVI).

From the vault: Origin of the market approach

When doing research using BVResearch Pro, you may stumble on some very interesting things in addition to what you’re specifically looking for.

Users Reveal Insights and Tips on DealStats and the GCTM

A valuation expert and a business broker/appraiser give some insight into the use of the new DealStats database and some comments on a few aspects of the guideline company transaction method.

101 - 125 of 154 results